Wird geladen...
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A
A 54-year-old man with a long history of severe haemophilia A treated prophylactically with efmoroctocog alpha (3,000 IU twice weekly) was diagnosed with COVID-19 infection. He had multiple risk factors for COVID-19 severity including obesity, diabetes mellitus and hypertension. He required prolonge...
Gespeichert in:
| Veröffentlicht in: | Acta Haematol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
S. Karger AG
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573908/ https://ncbi.nlm.nih.gov/pubmed/32980842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510591 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|